|
|
|
In March 2007, the FDA issued a black-box warning for erythropoiesis-stimulating agents. It is recommended that the lowest possible dose be used to help patients avoid blood transfusions. Studies have shown increased mortality and/or a tumor progression in patients with cancer receiving an erythropoiesis-stimulating agent.
For more information, please review the FDA Fact Sheet available
online at:
http://www.fda.gov/cder/drug/infopage/RHE/default.htm
|
|
|
| | | [Top] |
| OVERVIEW |
|
| Anemia is common among critically ill patients, affecting 29%–77% depending on the report. In such patients, common comorbidities such as multiple-organ failure, sepsis, myocardial ischemia, pulmonary edema, and others can severely affect normal compensatory mechanisms and severely diminish their ability to tolerate even mild degrees or short durations of anemia. Therefore, anemia management in this population is aimed at the early detection of risk factors and the prompt institution of evidence-based therapies.
|
| | | [Top] |
| OBJECTIVES |
|
|
Upon completion of this course, you should be able to: |
| |
-
Describe the major risk factors for anemia in critically ill patients
-
Name the goals of anemia management in the intensive care setting
-
Appropriately select blood transfusion or pharmacologic options for critically ill patients at risk for anemia
|
| | | [Top] |
| TARGET AUDIENCE |
|
| This CME activity is designed for critical care physicians, critical care nurses, and other healthcare providers who treat patients with risk factors for anemia. |
| | | [Top] |
| FACULTY |
| |
|
|
 |
| Leo C. Rotello, MD, FCCP
[BioSketch]
|
| Medical Director, Medical/Surgical Intensive Care Unit, Suburban Hospital, and Director of Clinical Operations, IntensiMed Corp., Bethesda, Md |
| Disclosure: No financial relationships with a commercial party to disclose. |
|
|
|
| | | [Top] |
|
|
| Accreditation
Statement |
| |
| Continuing Medical Education for Physicians |
 |
| Accreditation Statement |
| MEBN is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. |
| |
| CME Credits |
| MEBN designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. |
| |
| FDA Disclosure Statement |
| The contents of some CME activities may contain discussions of non-approved or off-label uses of some of the agents mentioned. Please consult the prescribing information for full disclosure of approved uses. |
| |
| Accreditation Period |
Original release date: March 23, 2006
Reviewed and Renewed: March 23, 2008
Expiration Date: March 23, 2009 |
| |
| Any questions regarding the accreditation of this CME activity should be directed to MEBN. (accreditation@mebn.net) | Continuing Education for Nurses
MEBN is an approved provider of continuing nursing education by the New Hampshire Nurses’ Association Commission on Continuing Education, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. MEBN recognizes that the accredited status refers only to our continuing nursing education activities and does not imply that the ANCC Commission on Accreditation approves or endorses these commercial products.
Contact Hours
MEBN designates this continuing education activity for up to 1 contact hour(s) of nursing continuing education credit.
Accreditation Period
Original release date: March 23, 2006
Reviewed and Renewed: March 23, 2008
Expiration Date: March 23, 2009 |
|
|
| | | [Top] |
| DISCLAIMER |
|
|
Disclaimer
This continuing education program may
contain discussion of published and/or investigational uses of agents or
products that are not approved by the Food and Drug Administration (FDA). The
authors, sponsors or publishers do not recommend the use of any agent or product
outside of the official labeled indications. Please refer to the official
prescribing information for each agent or product for discussion of approved
indications, contraindications, and written warnings.
Any procedures, medications, or other courses of diagnosis or
treatment discussed or suggested in this course should not be used by clinicians
without evaluation of their patient's conditions and possible contraindications
on dangers in use, review of any applicable manufacturer's product information,
and comparison with recommendations of other authorities.
The authors, contributors, and editorial staff have made
every effort to contact holders of copyright to obtain permission to reproduce
copyright material. However, if any permissions have been inadvertently
overlooked, MEBN will be pleased to make the necessary and reasonable
arrangements. |
| | | [Top] |
| How to Take This Course |
|
|
Choose Your Format To Begin Course: |
| |
|
|
| |
| | | [Top] |
| SUPPORTERS |
|
Supported by an educational grant from:
| |
|
| | | [Top] |
| CERTIFICATE FEES |
|
| This course certificate is FREE to qualified attendees. |
| | | [Top] |
|
|
